Drug details

Revatio (sildenafil citrate)

type of PAH, PDE-5 Inhibitors, Phosphodiesterase-5 Enzyme Inhibitors

Revatio (sildenafil), a cyclic GMP inhibitor, is indicated for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening. Revatio is also used to treat erectile dysfunction. Revatio is available as a generic.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• severe shortness of breath,
• pain spreading to your jaw or shoulder,
• sweating,
• chest pain or pressure,
• irregular heartbeat,
• vision changes,
• ringing in your ears,
• sudden vision loss,
• cough with foamy mucus,
• swelling in your hands, ankles, or feet,
• seizures, and
• erection is painful or lasts longer than 4 hours,
• sudden hearing loss,
• lightheadedness  

The following drugs are related to Revatio, either as a replacement or used together:

• Adempas (riociguat tablets)
• Alyq (tadalafil tablets)
• Letairis (ambrisentan tablets)
• Stendra (avanafil)
• Tracleer (bosentan)
• Veletri (epoprostenol powder for intravenous administration)
• Flolan (epoprostenol sodium)
• Ventavis (iloprost)
• Liqrev (sildenafil oral suspension)
• Remodulin (treprostinil sodium)
• Staxyn (vardenafil hydrochloride orally disintegrating tablets)
• Tadliq (tadalafil oral suspension)
• Tyvaso DPI (treprostinil inhalation powder)
• Uptravi (uptravi selexipag tablets)